Scientific Session
Immunotherapy including CAR-T Therapy
Joan Merrill, MD
OMRF Professor of Medicine
Oklahoma Medical Research Foundation
Oklahoma City 73104, OK, United States
Disclosure(s): AbbVie/Abbott: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Alumis: Consultant (Ongoing); Amgen: Consultant (Ongoing); AstraZeneca: Consultant (Ongoing); Aurinia: Consultant (Ongoing); Autolus: Consultant (Ongoing); Biogen: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Bristol-Myers Squibb(BMS): Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Duality: Consultant (Ongoing); Eli Lilly: Consultant (Ongoing); EMD Serono: Consultant (Ongoing); Equillium: Consultant (Ongoing); Genentech: Consultant (Ongoing); GlaxoSmithKlein(GSK): Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Kezar: Consultant (Ongoing); Merck/MSD: Consultant (Ongoing); Novartis: Consultant (Ongoing); Ono: Consultant (Ongoing); Remegen: Consultant (Ongoing); Sanofi: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Takeda: Consultant (Ongoing); Tenent: Consultant (Ongoing); UCB: Consultant (Ongoing); Zenas: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)